(Q70022010)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949059%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

title

Selective D-1 dopamine receptor agonist treatment of Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949059%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949059%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

M. Maral Mouradian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949059%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

author name string

A Braun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949059%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

C Serrati

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949059%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

P Barone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949059%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

T N Chase

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949059%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

publication date

1 January 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949059%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949059%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

page(s)

41-50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949059%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949059%20AND%20SRC:MED&resulttype=core&format=json

The central effects of a novel dopamine agonist

7 October 2019

cites work

1 reference

12 December 2020

Multiple receptors for dopamine

1 reference

12 December 2020

1 reference

12 December 2020

Lisuride in parkinsonism

1 reference

12 December 2020

Parkinsonism: onset, progression, and mortality

1 reference

12 December 2020

Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions

1 reference

12 December 2020

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

1 reference

12 December 2020

Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390

1 reference

12 December 2020

SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions

1 reference

12 December 2020

Intravenous lisuride corrects oscillations of motor performance in Parkinson's disease

1 reference

12 December 2020

Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions

1 reference

12 December 2020

The effect of bromocriptine on rat striatal adenylate cyclase and rat brain monoamine metabolism

1 reference

12 December 2020

Behavioral correlations of dopamine receptor activation

1 reference

12 December 2020

The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset

1 reference

12 December 2020

Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.

1 reference

12 December 2020

Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

1 reference

12 December 2020

Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide

1 reference

12 December 2020

Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.

1 reference

12 December 2020

Behavioural correlates to the dopamine D-1 and D-2 antagonists

1 reference

12 December 2020

[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease.

1 reference

12 December 2020

Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease

1 reference

12 December 2020

Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

1 reference

12 December 2020

Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis

1 reference

12 December 2020

The Classification of Dopamine Receptors: Relationship to Radioligand Binding

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01244638

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949059%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference